查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556195

2024 年人工胰臟装置系统全球市场报告

Artificial Pancreas Device System Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

人工胰臟设备系统的市场规模预计在未来几年将快速成长。 2028年，这一数字将以14%的复合年增长率成长至30.6亿美元。预测期内的预期增长是由糖尿病患病率上升、胰腺癌发病率上升、糖尿病和肥胖率上升、对微创 (MI) 给药系统的需求不断增长以及糖尿病管理技术推动的。预测期内的主要趋势包括技术创新、加强研发力度、增加产品核可、扩大伙伴关係和协作以及增加后续远端咨询活动。

胰臟癌盛行率的增加预计将推动人工胰臟装置系统（APDS）市场的扩张。胰臟癌是一种发生在位于胃后方的胰臟的恶性。胰臟癌的发展受到生活方式、遗传、医疗和环境因素的综合影响，包括引起遗传性胰臟炎并导致慢性胰臟炎的基因突变。人工胰臟装置系统主要旨在透过自动监测血糖并输送适量的胰岛素来帮助糖尿病患者管理血糖值。例如，2024 年 3 月，澳洲政府机构 TheCancer Australia 估计，2023 年将有 4,506 例新诊断的胰臟癌病例，高于前五年的 3,751 例。因此，胰臟癌盛行率的上升促进了人工胰臟设备系统市场的成长。

人工胰臟设备系统市场的主要参与者正在开发自动化胰岛素输送系统，透过自动监测血糖值和施用适量的胰岛素来改善糖尿病管理。这些系统旨在模仿健康胰臟的功能，减少持续血糖值监测和手动胰岛素注射的需要。例如，2023 年 5 月，美国医疗设备製造商 Beta Bionics 的自动胰岛素给药设备 iLet 仅胰岛素仿生胰臟系统获得 FDA 510(k) 许可。这种人工胰臟系统自主地确定和管理胰岛素剂量以调节血糖值。此封闭式系统根据连接的连续血糖监测仪（CGM）测量的血糖水平调整胰岛素剂量，并且仅需要估计值用户的体重和膳食量即可进行自动调整。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球人工胰臟设备系统市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球人工胰臟装置系统市场表现：规模与成长，2018-2023
  • 全球人工胰臟装置系统市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球人工胰臟装置系统市场：按装置类型分類的性能和预测，2018-2023、2023-2028F、2033F
  • 阈值暂停装置系统
  • 控制距离系统
  • 控制目标系统
  • 全球人工胰臟装置系统市场：依治疗类型分類的表现与预测，2018-2023、2023-2028F、2033F
  • 双激素
  • 仅胰岛素
  • 混合
  • 全球人工胰臟装置系统市场：最终用户的表现与预测，2018-2023、2023-2028F、2033F
  • 医院
  • 医疗中心
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球人工胰臟装置系统市场：按地区分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 全球人工胰臟装置系统市场：按国家分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 人工胰臟装置系统市场：竞争格局
  • 人工胰臟设备系统市场：公司简介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • DexCom Inc.
    • Insulet Corporation

第31章 其他大型创新企业

  • Tandem Diabetes Care Inc.
  • Juvenile Diabetes Research Foundation（JDRF）
  • Beta Bionics Inc.
  • Glooko Inc.
  • Bigfoot Biomedical Inc.
  • CeQur SA
  • Medtrum Technologies Inc.
  • Diabeloop SA
  • Beta-O2 Technologies Ltd
  • Pancreum Inc.
  • TypeZero Technologies LLC
  • Inreda Diabetic BV
  • Defymed SAS
  • Admetsys Corporation
  • DreaMed Diabetes Ltd

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r19543

An Artificial Pancreas Device System (APDS) is a medical technology designed to automate blood glucose management for people with diabetes. This system combines continuous glucose monitoring (CGM) with an insulin pump and employs a sophisticated algorithm to adjust insulin delivery automatically based on real-time glucose readings. The goal of the device is to replicate the glucose-regulating function of a healthy pancreas, thus minimizing the need for manual blood glucose monitoring and insulin injections, and assisting in keeping blood glucose levels within a target range.

The artificial pancreas device system market features three main types of devices threshold suspend device systems, control-to-range systems, and control-to-target systems. Threshold suspend device systems are insulin pump technologies that automatically halt insulin delivery when blood glucose levels fall below a set threshold. The different treatment types include bi-hormonal, insulin-only, and hybrid systems, with end-users such as hospitals, medical centers, and other healthcare settings.

The artificial pancreas device system market research report is one of a series of new reports from The Business Research Company that provides artificial pancreas device system market statistics, including the artificial pancreas device system industry global market size, regional shares, competitors with artificial pancreas device system market share, detailed artificial pancreas device system market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial pancreas device system industry. These artificial pancreas device system market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.81 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The increase observed during the historic period can be attributed to several factors, including the rising influx of investments, expanding government initiatives in clinical research, increasing demand for automated glycemic control systems, intensive research and development efforts by industry players, and a growing geriatric population.

The artificial pancreas device system market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2028 at a compound annual growth rate (CAGR) of 14%. The anticipated growth during the forecast period can be attributed to the rising prevalence of diabetes, the increasing incidence of pancreatic cancer, the growing rates of diabetes and obesity, the higher demand for minimally invasive (MI) drug delivery systems, and advancements in diabetes management technology. Key trends in the forecast period include technological innovations, heightened research and development efforts, a rise in product approvals, growing partnerships and collaborations, and an increase in teleconsultancy activities for follow-up.

The growing incidence of pancreatic cancer is projected to drive the expansion of the artificial pancreas device system (APDS) market. Pancreatic cancer is a malignant tumor originating in the pancreas, which is located behind the stomach. The development of pancreatic cancer is influenced by a mix of lifestyle, genetic, medical, and environmental factors, including genetic mutations that can cause hereditary pancreatitis and result in chronic pancreatic inflammation. An artificial pancreas device system is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For example, in March 2024, according to theCancer Australia, an Australia-based government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, up from 3,751 cases over the previous five years. Thus, the rising prevalence of pancreatic cancer is contributing to the growth of the artificial pancreas device system market.

Key players in the artificial pancreas device system market are developing automated insulin delivery systems to improve diabetes management by automatically monitoring blood glucose levels and administering the correct amount of insulin. These systems aim to mimic the function of a healthy pancreas, alleviating the need for constant blood sugar monitoring and manual insulin injections. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system autonomously determines and delivers insulin doses to regulate blood glucose levels. The closed-loop system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM), requiring only the user's body weight and a meal size estimate for automatic adjustments.

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by integrating its leading Freestyle Libre continuous glucose monitoring technology with Bigfoot Biomedical's expertise in automated insulin delivery systems. Bigfoot Biomedical, a US-based company, specializes in developing prototypes of automated insulin delivery systems, also known as artificial pancreas systems.

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial pancreas device system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial pancreas device system market includes revenues earned by entities by providing services such as patient monitoring, device maintenance, data management, software updates, healthcare provider consultations, and training and support for patients and healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial pancreas device system market also includes sales of insulin pumps, continuous glucose monitors, control algorithms and software applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Pancreas Device System Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial pancreas device system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial pancreas device system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial pancreas device system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
  • 2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
  • 3) By End-User: Hospitals; Medical Centers; Other End-Users
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; DexCom Inc.; Insulet Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Pancreas Device System Market Characteristics

3. Artificial Pancreas Device System Market Trends And Strategies

4. Artificial Pancreas Device System Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Pancreas Device System Market Size and Growth

  • 5.1. Global Artificial Pancreas Device System Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Pancreas Device System Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Pancreas Device System Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Pancreas Device System Market Segmentation

  • 6.1. Global Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Threshold Suspend Device Systems
  • Control-To-Range Systems
  • Control-To-Target Systems
  • 6.2. Global Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bi-Hormonal
  • Insulin Only
  • Hybrid
  • 6.3. Global Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Medical Centers
  • Other End-Users

7. Artificial Pancreas Device System Market Regional And Country Analysis

  • 7.1. Global Artificial Pancreas Device System Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Pancreas Device System Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Pancreas Device System Market

  • 8.1. Asia-Pacific Artificial Pancreas Device System Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Pancreas Device System Market

  • 9.1. China Artificial Pancreas Device System Market Overview
  • 9.2. China Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Pancreas Device System Market

  • 10.1. India Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Pancreas Device System Market

  • 11.1. Japan Artificial Pancreas Device System Market Overview
  • 11.2. Japan Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Pancreas Device System Market

  • 12.1. Australia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Pancreas Device System Market

  • 13.1. Indonesia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Pancreas Device System Market

  • 14.1. South Korea Artificial Pancreas Device System Market Overview
  • 14.2. South Korea Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Pancreas Device System Market

  • 15.1. Western Europe Artificial Pancreas Device System Market Overview
  • 15.2. Western Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Pancreas Device System Market

  • 16.1. UK Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Pancreas Device System Market

  • 17.1. Germany Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Pancreas Device System Market

  • 18.1. France Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Pancreas Device System Market

  • 19.1. Italy Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Pancreas Device System Market

  • 20.1. Spain Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Pancreas Device System Market

  • 21.1. Eastern Europe Artificial Pancreas Device System Market Overview
  • 21.2. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Pancreas Device System Market

  • 22.1. Russia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Pancreas Device System Market

  • 23.1. North America Artificial Pancreas Device System Market Overview
  • 23.2. North America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Pancreas Device System Market

  • 24.1. USA Artificial Pancreas Device System Market Overview
  • 24.2. USA Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Pancreas Device System Market

  • 25.1. Canada Artificial Pancreas Device System Market Overview
  • 25.2. Canada Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Pancreas Device System Market

  • 26.1. South America Artificial Pancreas Device System Market Overview
  • 26.2. South America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Pancreas Device System Market

  • 27.1. Brazil Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Pancreas Device System Market

  • 28.1. Middle East Artificial Pancreas Device System Market Overview
  • 28.2. Middle East Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Pancreas Device System Market

  • 29.1. Africa Artificial Pancreas Device System Market Overview
  • 29.2. Africa Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Pancreas Device System Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Pancreas Device System Market Competitive Landscape
  • 30.2. Artificial Pancreas Device System Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. DexCom Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Insulet Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Pancreas Device System Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Juvenile Diabetes Research Foundation (JDRF)
  • 31.3. Beta Bionics Inc.
  • 31.4. Glooko Inc.
  • 31.5. Bigfoot Biomedical Inc.
  • 31.6. CeQur SA
  • 31.7. Medtrum Technologies Inc.
  • 31.8. Diabeloop SA
  • 31.9. Beta-O2 Technologies Ltd
  • 31.10. Pancreum Inc.
  • 31.11. TypeZero Technologies LLC
  • 31.12. Inreda Diabetic B.V.
  • 31.13. Defymed SAS
  • 31.14. Admetsys Corporation
  • 31.15. DreaMed Diabetes Ltd

32. Global Artificial Pancreas Device System Market Competitive Benchmarking

33. Global Artificial Pancreas Device System Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market

35. Artificial Pancreas Device System Market Future Outlook and Potential Analysis

  • 35.1 Artificial Pancreas Device System Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Pancreas Device System Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Pancreas Device System Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer